- Home
- Your Messages
-
Smartest Doc
Daily Quiz CompetitionTest your clinical knowledge against other physicians in the USA by taking our FREE daily quiz!
New! PHYSICIAN REVIEW
Thousands of questions to assess your knowledge and aid exam prep!
- Physician Jobs (158)
- More
- Other Specialty
Rheumatology - Vasculitic Syndromes News & Articles
What you'll find here at MDLinx Rheumatology: The top rheumatology clinical articles of the day, plus MDLinx exclusive content
- Our medical editors bring you the best key learnings published in the top peer-reviewed rheumatology medical journals. You'll find overviews here ranked and organized by topic on rheumatoid arthritis, joint and back pain, osteoarthritis, lupus and autoimmune diseases, osteoporosis and bone fractures. In a matter of minutes, you and all the members of your patient care team can stay current on the literature as it is published.
- MDLinx exclusive content includes monthly highlights from our physician editor, D. Scott Cunningham, MD, PhD, as well as clinical pearls from The Smartest Internist, The Smartest Family Physician, and The Smartest Pediatrician daily quiz challenges.
Your Unread Messages in Rheumatology
See All >> Messages include industry-sponsored communications and special communications from MDLinx-
Patients 50+ may be at increased risk for pneumococcal disease. Learn what you can do. -
MDLinx Reminder
MDLinx
Did you see this newsletter? -
Smartest Doc Challenge
MDLinx
Pediatric and Adolescent Sports Injury Clinical Pearls -
D Scott Cunningham MD, PhD
Site Editor, MDLinx
Mirtazapine effective in treating fibromyalgia -
MDLinx Top Read
MDLinx
Are your journals collecting cobwebs? -
MDLinx Conference Center
MDLinx
June Conference Calendar
Articles
Latest (1) Full Text Articles (11) Focus on Gout481 Hypertrophic Spinal Pachymeningitis With Thoracic Myelopathy: The Initial Presentation of ANCA-related Systemic Vasculitis Journal of Spinal Disorders & Techniques, December 1, 2011
482 Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis Seminars in Arthritis and Rheumatism, November 30, 2011
483 Rituximab maintenance therapy for granulomatosis with polyangiitis and microscopic polyangiitis The Journal of Rheumatology, November 28, 2011 Clinical Article
484 Clinical significance of cryofibrinogenemia: Possible pathophysiological link with Raynaud's phenomenon The Journal of Rheumatology, November 28, 2011
485 Interleukin-1{beta}-regulating antibody XOMA 052 (gevokizumab) in the treatment of acute exacerbations of resistant uveitis of Behcets disease: An open-label pilot study Annals of Rheumatic Diseases, November 22, 2011
486 The impact of 18F-FDG PET on the management of patients with suspected large vessel vasculitis European Journal of Nuclear Medicine & Molecular Imaging, November 22, 2011
487 Biologic treatment of large-vessel vasculitides Current Opinion in Rheumatology, November 18, 2011
488 CD40 gene polymorphisms confer risk of Behcet's disease but not of Vogt–Koyanagi–Harada syndrome in a Han Chinese population Rheumatology, November 17, 2011
489 Neoplastic and Paraneoplastic Vasculitis, Vasculopathy, and Hypercoagulability Rheumatic Disease Clinics of North America, November 15, 2011
490 Tocilizumab: A novel therapy for patients with large-vessel vasculitis Rheumatology, November 14, 2011 Clinical Article
491 Childhood primary angiitis of the CNS (cPACNS): Identifying disease trajectories and early risk factors for persistently higher disease activity Arthritis & Rheumatism, November 14, 2011
492 Rituximab for refractory granulomatosis with polyangiitis (Wegeners granulomatosis): Comparison of efficacy in granulomatous versus vasculitic manifestations Annals of Rheumatic Diseases, November 9, 2011 Clinical Article
493 Behçets disease and genes within the major histocompatibility complex region Modern Rheumatology, November 7, 2011
494 Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis—a meta-analysis Rheumatology, November 3, 2011
495 The role of resistin in Behçets disease: A Turkish experiment Modern Rheumatology, November 3, 2011
496 The role of biologics in treatment of ANCA-associated vasculitis Modern Rheumatology, November 2, 2011
497 Combination therapy with rituximab and cyclophosphamide in the treatment of anti-neutrophil cytoplasmic antibodies (ANCA) positive pulmonary hemorrhage: case report Pediatric Rheumatology, October 31, 2011
498 The Role of Tumor Necrosis Factor-α Promoter Genetic Variation in Takayasu Arteritis Susceptibility and Medical Treatment The Journal of Rheumatology, October 25, 2011
499 HIV Infection and Clinical Spectrum of Associated Vasculitides Current Rheumatology Reports, October 18, 2011
500 Concurrence of malignant fibrohistiocytoma and Takayasu arteritis: a case report Rheumatology International, October 17, 2011
Clinical Pearls in Rheumatology
- Independent predictors of disease activity in patients with systemic lupus include age, renal activity, immunosuppressant use and pre-existing organ damage
- When treating rheumatoid arthritis (RA), male sex, short duration of symptoms and less tender joints at baseline were found to be independent predictors of sustained remission with conventional DMARDs
- Higher baseline DAS28 scores and positive rheumatoid factor status are significantly associated with an improvement in response to rituximab treatment
Highlights in Rheumatology
ACPA correlate with disease progression in JIA
In a study involving 74 patients with juvenile idiopathic arthritis (JIA), 26 patients had detectable anti-citrullinated protein antibodies (ACPA). The ACPA titers correlated with disease progression at baseline and after a median follow-up of 11.5 months. In addition to predicting disease severity and progression, the authors concluded that ACPA were superior to IgM-RF in diagnosing JIA.
Read the article summaryPredicting cardiovascular mortality in SLE
In a study involving 208 patients with SLE followed for 12 years, 42 deaths occurred, 48% of which were considered to be cardiovascular mortalities. Age, increased cystatin C levels, and arterial disease were predictive of all-cause mortality. Cigarette smoking and increased sVCAM-1, hsCRP, abeta2GP1, and aPL antibody levels were predictive of cardiovascular mortality.
Read the article summaryAnti-apoA-1 antibodies predict cardiovascular disease in RA patients
In a study conducted at the University of Geneva involving 118 patients with rheumatoid arthritis, but without cardiovascular disease at baseline, the 10-year Framingham cardiovascular risk score (FRS) was improved with the inclusion of the anti-apoA-1 antibody titer. The median follow-up was 9 years and the incidence of cardiovascular disease was 16%. Other biomarkers, including the NT-proBNP, oxLDL, CRP, and RF levels and the anti-citrullinated peptide antibody titer, did not improve the FRS.
Read the article summaryMost Popular Rheumatology Articles
Last month's top read Top Articles of 20121 Crosstalk between inflammation, iron metabolism and endotelial function in Behcets disease Clinical Hemorheology and Microcirculation, May 1, 2013
2 Changes in biomarkers after therapeutic intervention in temporal arteries cultured in Matrigel: a new model for preclinical studies in giant-cell arteritis Annals of Rheumatic Diseases, May 7, 2013
3 Maintaining remission in granulomatosis with polyangiitis (Wegener’s) International Journal of Clinical Rheumatology, March 15, 2013 Review Article
4 Movement disorders in systemic lupus erythematosus and the antiphospholipid syndrome Journal of Neural Transmission, May 2, 2013 Review Article
5 A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg-Strauss, EGPA): monocentric experiences in 150 patients Annals of Rheumatic Diseases, May 23, 2013
6 Granulocyte colony stimulating factor exacerbates antineutrophil cytoplasmic antibody vasculitis Annals of Rheumatic Diseases, May 22, 2013 Review Article
7 State of art on nailfold capillaroscopy: a reliable diagnostic tool and putative biomarker in rheumatology Rheumatology, May 8, 2013
8 Use of New Oral Anticoagulants in Antiphospholipid Syndrome Current Rheumatology Reports, May 7, 2013
9 Regulatory B cells in ANCA-associated vasculitis Annals of Rheumatic Diseases, May 29, 2013
10 Alpha 1-antitrypsin activity is markedly decreased in Wegeners granulomatosis Rheumatology International, May 1, 2013 Review Article
11 Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group Annals of Rheumatic Diseases, May 8, 2013 Review Article
12 Overview of vasculitis and vasculopathy in rheumatoid arthritis--something to think about Clinical Rheumatology, May 7, 2013 Review Article
13 Long-term outcomes of 118 patients with eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome) enrolled in two prospective trials Journal of Autoimmunity , April 24, 2013
14 Persistent antiphospholipid antibodies do not contribute to adverse pregnancy outcomes Rheumatology, May 20, 2013 Review Article
15 Remarks on the Asia Pacific Meeting of Vasculitis and ANCA Workshop 2012 Clinical and Experimental Nephrology, May 10, 2013 Review Article
16 Childhood-onset Eosinophilic Granulomatosis with Polyangiitis (formerly Churg-Strauss Syndrome): A Contemporary Single-center Cohort The Journal of Rheumatology, May 3, 2013
17 Statin Use in Giant Cell Arteritis: A Retrospective Study The Journal of Rheumatology, April 3, 2013
18 Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis Annals of Rheumatic Diseases, May 21, 2013
19 Anti-carbonic anhydrase III autoantibodies in vasculitis syndrome International Journal of Rheumatic Diseases, May 24, 2013 Review Article
20 Granulomatosis with polyangiitis presenting as henoch-schonlein purpura in children JCR: Journal of Clinical Rheumatology, May 23, 2013
Indexed Journals in Rheumatology: Arthritis & Rheumatism, Annals of Rheumatic Diseases, Journal of Rheumatology more
Other Topics in Rheumatology
Register now to view all the MDLinx contents (FREE)!
- Stay current on the latest literature, research and clinical news
- Get special communications and offers from MDLinx and our sponsors
- Receive invitations to paid market research
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close